Physician profile
Wallace L Huff
NPI 1184619314
$4,724.15
in general payments reported to CMS, 2019-2025
23 companies · $503 in 2025
The $503 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,104 · 2020: $515 · 2021: $547 · 2022: $583 · 2023: $378 · 2024: $94.95 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $1,190.42 | 2019 | |
| Pacira Therapeutics, INC. | $678.08 | 2019-2021 | |
| Stryker Corporation | $629.84 | 2019-2024 | Air, Flexible Guide Pin (Stryker Acl Versitomic), Tritanium |
| Depuy Synthes Sales INC. | $566.25 | 2019-2025 | Dynacord, Gryphon Orthocord |
| Smith+Nephew, INC. | $434.98 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $276.65 | 2019-2025 | Oxford Partial Knee, Juggerknotless Soft Anchor |
| Pacira Pharmaceuticals Incorporated | $221.91 | 2021-2025 | Zilretta, Iovera |
| Biotissue Holdings INC. | $170.25 | 2025 | |
| Kci USA, INC. | $132.97 | 2020-2023 | Prevena, V.A.C.Ulta |
| Restor3d, INC. | $76.58 | 2024 | |
| Horizon Therapeutics Plc | $65.52 | 2022 | |
| Vericel Corporation | $37.46 | 2019-2022 | |
| Dynasplint Systems INC. | $37.04 | 2019 | |
| Ethicon US, LLC | $35.11 | 2020-2021 | |
| Bioventus LLC | $32.07 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $30.12 | 2023 | Euflexxa |
| Medartis INC. | $27.73 | 2019 | |
| Fidia Pharma USA INC. | $19.61 | 2025 | Triluron, Hymovis |
| Orthogenrx INC. | $18.18 | 2019 | |
| Legacy Ortho LLC | $17.32 | 2023 | |
| Medtronic USA, INC. | $14.34 | 2019 | |
| Pfizer INC. | $11.72 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$79,987.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.